Audrey Gill

406 total citations
4 papers, 43 citations indexed

About

Audrey Gill is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Audrey Gill has authored 4 papers receiving a total of 43 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Audrey Gill's work include Prostate Cancer Treatment and Research (4 papers), Cancer Genomics and Diagnostics (2 papers) and Advanced Breast Cancer Therapies (1 paper). Audrey Gill is often cited by papers focused on Prostate Cancer Treatment and Research (4 papers), Cancer Genomics and Diagnostics (2 papers) and Advanced Breast Cancer Therapies (1 paper). Audrey Gill collaborates with scholars based in United States, United Kingdom and Greece. Audrey Gill's co-authors include Howard I. Scher, Emily Carbone, Joseph D. Schonhoft, Adam Jendrisak, Ethan Barnett, Ryan Dittamore, Samuel F. Bakhoum, Mark Landers, Melanie Hullings and Jimmy L. Zhao and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Audrey Gill

3 papers receiving 42 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Audrey Gill United States	3	24	23	19	19	5	4	43
José Rodrigo Espinosa Fernández United States	5	44 1.8×	26 1.1×	17 0.9×	10 0.5×	3 0.6×	9	68
Jill D. Kremer United States	5	24 1.0×	14 0.6×	30 1.6×	15 0.8×	12 2.4×	11	58
Pierre Painsec France	2	28 1.2×	16 0.7×	28 1.5×	18 0.9×	4 0.8×	4	51
Bomiao Hu United States	2	25 1.0×	10 0.4×	21 1.1×	25 1.3×	3 0.6×	3	46
Brittney Gordon United States	3	16 0.7×	15 0.7×	36 1.9×	23 1.2×	5 1.0×	5	59
Houjie Liang China	4	17 0.7×	20 0.9×	25 1.3×	8 0.4×	2 0.4×	8	52
E. Shelley Hwang United States	3	11 0.5×	20 0.9×	30 1.6×	8 0.4×	6 1.2×	3	48
Erik Tilch Germany	3	40 1.7×	20 0.9×	39 2.1×	16 0.8×	8 1.6×	5	75
Simon Ying Kit Law Hong Kong	3	14 0.6×	19 0.8×	24 1.3×	18 0.9×	2 0.4×	4	60
Linda Grob Switzerland	3	28 1.2×	17 0.7×	25 1.3×	11 0.6×	2 0.4×	5	50

Countries citing papers authored by Audrey Gill

Since Specialization

Citations

This map shows the geographic impact of Audrey Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audrey Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audrey Gill more than expected).

Fields of papers citing papers by Audrey Gill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Audrey Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audrey Gill. The network helps show where Audrey Gill may publish in the future.

Co-authorship network of co-authors of Audrey Gill

This figure shows the co-authorship network connecting the top 25 collaborators of Audrey Gill. A scholar is included among the top collaborators of Audrey Gill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Audrey Gill. Audrey Gill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Bono, Johann S. de, Klaus Pantel, Eleni Efstathiou, et al.. (2021). CTC counts as a biomarker of prognosis and response in metastatic castration-resistant prostate cancer (mCRPC) from the CARD trial.. Journal of Clinical Oncology. 39(6_suppl). 161–161. 3 indexed citations

2.

Lu, David, Rachel Krupa, Melissa Harvey, et al.. (2020). Development of an immunofluorescent AR-V7 circulating tumor cell assay – A blood-based test for men with metastatic prostate cancer. SHILAP Revista de lepidopterología. 9(1). 13–19. 8 indexed citations

3.

Schonhoft, Joseph D., Jimmy L. Zhao, Adam Jendrisak, et al.. (2020). Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate Cancer. Cancer Research. 80(22). 4892–4903. 32 indexed citations

4.

Scher, Howard I., Adam Jendrisak, Audrey Gill, et al.. (2020). Circulating tumor cells (CTCs) with small-cell like pathology are prevalent in metastatic castration-resistant prostate cancer (mCRPC) and show selective pharmacodynamic reductions in patients treated with platinum but not ARSI or taxane.. Journal of Clinical Oncology. 38(15_suppl). 5572–5572.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact